William Aliski, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 10,000 shares at $86.57 ($866K) on 2020-08-21, disclosed to the SEC on 2020-08-25.
Open-market sale of $866k RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.57 | 5,000 | $433K | 50.0% |
| 2 | $86.57 | 5,000 | $433K | 50.0% |
| Total | $86.57 avg | 10,000 | $866K | 100% |
| Filing → |
| RARE | SELL | 2020-05-20 | $560K | — | Filing → |
| AGTC | BUY | 2018-12-18 | $19K | — | Filing → |
| RARE | SELL | 2018-12-07 | $298K | — | Filing → |